North America Injectable Drug Delivery Market – Industry Trends and Forecast to 2027

  • Pharmaceutical
  • Upcoming Report
  • Jun 2020
  • North America
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

North America Injectable Drug Delivery Market, By Type (Injectable Drug Delivery Devices, Injectable Drug Delivery Formulation), Application (Autoimmune Disease, Hormonal Disorders, Orphan Diseases, Oncology, Others), Usage Pattern (Curative Care, Immunization, Other), Mode Of Administration (Skin, Circulatory/Muskoskeletal, Organs, Central Nervous System), End User (Hospitals and Clinics, Home Healthcare, Research Laboratories, Pharmaceutical and Biotechnological Companies, Others), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Direct Tender, Online Pharmacy), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2027

North America Injectable Drug Delivery Market

Market Analysis and Insights: North America Injectable Drug Delivery Market

Injectable drug delivery market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 416.62 billion by 2027 growing at a CAGR of 11.35% in the above-mentioned forecast period. The growing demand of self- injection devices will help in driving the growth of the injectable drug delivery market.

Increasing occurrences of chronic diseases, surging levels of investment for the development of advanced technology, spending on pharma medicines and growth in the biologics market and the rising demand for vaccines, insulin, human growth hormone, and many modern medicines used to treat cancer and other chronic diseases will likely to accelerate the growth of the injectable drug delivery market in the forecast period of 2020-2027. On the other hand, growing demand for biosimilar and generic injectable will further boost various opportunities that will lead to the growth of the injectable drug delivery market in the above mentioned forecast period.

Infections associated with needlestick injuries and product recalls will likely to hamper the growth of the injectable drug delivery market in the above mentioned forecast period.

The growing preference of the alternative modes in drug delivery is posing a challenge to the injectable drug delivery market.

This injectable drug delivery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info on injectable drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

North America Injectable Drug Delivery Market Scope and Market Size

Injectable drug delivery market is segmented on the basis of type, application, usage pattern, mode of administration, end user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of type, the injectable drug delivery market is segmented into injectable drug delivery devices, injectable drug delivery formulation. The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation.
  • Based on application, the injectable drug delivery market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology, others. The autoimmune diseases segment is further sub segmented into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others. Hormonal disorders are further sub segmented into diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others.
  • Based on usage pattern, the injectable drug delivery market is segmented into curative care, immunization, other.
  • On the basis of mode of administration, the injectable drug delivery market is segmented into skin, circulatory/muskoskeletal, organs, central nervous system.
  • Injectable drug delivery market has also been segmented based on the end user into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others.
  • Based on distribution channel, the injectable drug delivery market is segmented into hospital pharmacy, pharmacy stores, direct tender and online pharmacy.

Injectable Drug Delivery Market Country Level Analysis

Injectable drug delivery market is analysed and market size insights and trends are provided by country, type, application, usage pattern, mode of administration, end user and distribution channel as referenced above.

The countries covered in the injectable drug delivery market report are the U.S., Canada and Mexico in North America.

North America dominates the injectable drug delivery market with the U.S. dominating the regions due to increasing incidence of chronic diseases, growth of biologic market and growing demand of self-injection devices.

The country section of the injectable drug delivery market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Injectable Drug Delivery Market Share Analysis

Injectable drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to injectable drug delivery market.

The major players covered in the injectable drug delivery market report are Baxter International, Inc., Becton Dickinson and Company, Gerresheimer AG, Pfizer, Inc., Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz, Terumo Corporation, Teva Pharmaceuticals Industries Ltd., Ypsomed, and Bespak among other domestic and North America players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available: North America Injectable Drug Delivery Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLE NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET

TABLE 1 LIST OF PRODUCT RECALL DRUGS TABLE 2 LIST OF DIFFERENT TYPES OF APPROVAL FOR DIFFERENT COUNTRIES TABLE 3 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION) TABLE 4 NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 5 NORTH AMERICA CONVENTIONAL DRUG DELIVERY MARKET, BY MATERIAL, 2015 – 2024 (USD MILLION) TABLE 6 NORTH AMERICA CONVENTIONAL DRUG DELIVERY MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION) TABLE 7 NORTH AMERICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION) TABLE 8 NORTH AMERICA SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 9 NORTH AMERICA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT,2015 – 2024 (USD MILLION) TABLE 10 NORTH AMERICA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 11 NORTH AMERICA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION) TABLE 12 NORTH AMERICA AUTO INJECTORSDEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION) TABLE 13 NORTH AMERICA AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 14 NORTH AMERICA AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION) TABLE 15 NORTH AMERICA AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION) TABLE 16 NORTH AMERICA PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION) TABLE 17 NORTH AMERICA PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION) TABLE 18 NORTH AMERICA PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION) TABLE 19 NORTH AMERICA INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION) TABLE 20 LIST OF SOME OF THE LYOPHILIZED FORMULATIONS TABLE 21 LIST OF SOME OF THE EMULSIONS TABLE 22 NORTH AMERICA CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION) TABLE 23 NORTH AMERICA NOVELDRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION) TABLE 24 NORTH AMERICA COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION) TABLE 25 LIST OF SOME OF THE NIOSOMES TABLE 26 LIST OF SOME OF THE LIPOSOMES TABLE 27 LIST OF SOME OF THE POLYMERIC MIXED MICELLES DRUG MANUFACTURER TABLE 28 LIST OF NANOSUSPENSION DRUG MANUFACTURER TABLE 29 LIST OF SOME OF THE NANOEMULSIONS/MICROEMULSIONS DRUG MANUFACTURER TABLE 30 LIST OF SOME OF THE SOLID LIPID NANOPARTICLES DRUG MANUFACTURER TABLE 31 NORTH AMERICA NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION) TABLE 32 LIST OF SOME OF THE MICROSPHERES DRUG MANUFACTURER TABLE 33 NORTH AMERICA MICROPARTICLESDRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION) TABLE 34 LIST OF SOME OF THE FIRST GENERATION LONG ACTING INJECTION TABLE 35 LIST OF SOME OF THE SECOND GENERATION LONG ACTING INJECTION: TABLE 36 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION,2015 – 2024 (USD MILLION) TABLE 37 NORTH AMERICA HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 38 NORTH AMERICA AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 39 LIST OF ORPHAN DISEASE IN INDIA (2010) TABLE 40 NORTH AMERICA OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 41 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION) TABLE 42 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION) TABLE 43 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 44 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION) TABLE 45 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 46 U.S. INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 47 U.S. INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 48 U.S. CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024 (USD MILLION) TABLE 49 U.S. CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 50 U.S. CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION) TABLE 51 U.S. SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 52 U.S. NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION) TABLE 53 U.S. NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 54 U.S. NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION) TABLE 55 U.S. AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION) TABLE 56 U.S. AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 57 U.S. AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION) TABLE 58 U.S. AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION) TABLE 59 U.S. PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION) TABLE 60 U.S. PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION) TABLE 61 U.S. PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION) TABLE 62 U.S. INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION) TABLE 63 U.S. CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION) TABLE 64 U.S. NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION) TABLE 65 U.S. COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION) TABLE 66 U.S. NANOPARTICLES COLLOIDAL DISPERSIONS NOVELDRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION) TABLE 67 U.S. MICROPARTICLES NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION) TABLE 68 U.S. INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 69 U.S. AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 70 U.S. HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 71 U.S. OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 72 U.S. INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION) TABLE 73 U.S. INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION) TABLE 74 U.S. INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 75 U.S. INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION) TABLE 76 CANADA INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 77 CANADA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 78 CANADA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024 (USD MILLION) TABLE 79 CANADA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 80 CANADA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION) TABLE 81 CANADA SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 82 CANADA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION) TABLE 83 CANADA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 84 CANADA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION) TABLE 85 CANADA AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION) TABLE 86 CANADA AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 87 CANADA AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION) TABLE 88 CANADA AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION) TABLE 89 CANADA PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION) TABLE 90 CANADA PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION) TABLE 91 CANADA PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION) TABLE 92 CANADA INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION) TABLE 93 CANADA CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION) TABLE 94 CANADA NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION) TABLE 95 CANADA COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION) TABLE 96 CANADA NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION) TABLE 97 CANADA MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION) TABLE 98 CANADA INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 99 CANADA AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 100 CANADA HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 101 CANADA OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 102 CANADA INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION) TABLE 103 CANADA INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION) TABLE 104 CANADA INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 105 CANADA INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION) TABLE 106 MEXICO INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 107 MEXICO INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 108 MEXICO CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024 (USD MILLION) TABLE 109 MEXICO CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 110 MEXICO CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION) TABLE 111 MEXICO SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 112 MEXICO NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION) TABLE 113 MEXICO NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 114 MEXICO NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION) TABLE 115 MEXICO AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION) TABLE 116 MEXICO AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 117 MEXICO AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION) TABLE 118 MEXICO AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION) TABLE 119 MEXICO PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION) TABLE 120 MEXICO PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION) TABLE 121 MEXICO PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION) TABLE 122 MEXICO INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION) TABLE 123 MEXICO CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION) TABLE 124 MEXICO NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION) TABLE 125 MEXICO COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION) TABLE 126 MEXICO NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION) TABLE 127 MEXICO MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION) TABLE 128 MEXICO INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 129 MEXICO AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 130 MEXICO HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 131 MEXICO OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 132 MEXICO INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION) TABLE 133 MEXICO INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION) TABLE 134 MEXICO INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 135 MEXICO INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19